Evidence map›Paper›PMID 41657782›Full record

ArticleSurgery in practice and science2026

Associations between obesity and lymph node metastasis and early recurrence in pancreatic head cancer: A single-center retrospective cohort study.

Kazuhiro Tada, Yo-Ichi Yamashita, Naotaka Inomata, Sota Nakamura, Shun Nakamura, Shohei Yoshiya, Yosuke Kuroda, Kentaro Iwaki, Shoji Hiroshige, Kengo Fukuzawa

Abstract read
In one paragraph

Article in Surgery in practice and science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kazuhiro TadaDepartment of Surgery, Japanese Red Cross Oita Hospital, 3-2-37 Chiyomachi, Oita-Shi, Oita, Japan.
Yo-Ichi YamashitaDepartment of Surgery, Japanese Red Cross Oita Hospital, 3-2-37 Chiyomachi, Oita-Shi, Oita, Japan.
Naotaka InomataDepartment of Surgery, Japanese Red Cross Oita Hospital, 3-2-37 Chiyomachi, Oita-Shi, Oita, Japan.
Sota NakamuraDepartment of Surgery, Japanese Red Cross Oita Hospital, 3-2-37 Chiyomachi, Oita-Shi, Oita, Japan.
Shun NakamuraDepartment of Surgery, Japanese Red Cross Oita Hospital, 3-2-37 Chiyomachi, Oita-Shi, Oita, Japan.
Shohei YoshiyaDepartment of Surgery, Japanese Red Cross Oita Hospital, 3-2-37 Chiyomachi, Oita-Shi, Oita, Japan.
Yosuke KurodaDepartment of Surgery, Japanese Red Cross Oita Hospital, 3-2-37 Chiyomachi, Oita-Shi, Oita, Japan.
Kentaro IwakiDepartment of Surgery, Japanese Red Cross Oita Hospital, 3-2-37 Chiyomachi, Oita-Shi, Oita, Japan.
Shoji HiroshigeDepartment of Surgery, Japanese Red Cross Oita Hospital, 3-2-37 Chiyomachi, Oita-Shi, Oita, Japan.
Kengo FukuzawaDepartment of Surgery, Japanese Red Cross Oita Hospital, 3-2-37 Chiyomachi, Oita-Shi, Oita, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Obesity may contribute to pancreatic cancer development via metabolic modulation. The number of obese patients with pancreatic cancer is expected to increase worldwide. Herein, we investigated the effects of obesity on patients with pancreatic head cancer who underwent pancreaticoduodenectomy (PD). Methods: We reviewed 141 consecutive PDs and compared clinicopathological factors and survival outcomes in obese (O: 29 patients) or non-obese (N: 112 patients) groups. Obesity was defined as a body mass index > 25 kg/m Results: Intraoperative bleeding was higher in the O group than in the N group (450 vs. 280 mL, Conclusions: Obesity was associated with early recurrence in patients undergoing PD for pancreatic head cancer.

Indexed as

Early recurrenceObesityPancreatic cancer

Identifiers

PMID41657782
PMCPMC12874787

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.